HCA Healthcare, Inc. Q3 2025 Earnings Recap

HCA Q3 2025 October 24, 2025

Get alerts when HCA reports next quarter

HCA Healthcare delivered robust third-quarter results with a 42% increase in adjusted diluted earnings per share and a 9.6% revenue growth, driven by volume expansion and improved payer mix.

Earnings Per Share Beat

$6.96 vs $5.79 est.

+20.2% surprise

Revenue Beat

19161000000 vs 18599805345 est.

+3.0% surprise

Market Reaction

1-Day +1.56%

5-Day +6.42%

30-Day +8.63%

See HCA alongside your other holdings

Add to your portfolio — free

Key Takeaways

Same facility equivalent admissions rose by 2.4%, reflecting strong demand for healthcare services.
Adjusted EBITDA margin improved, significantly aided by effective labor and supply cost management.
Revenue from Medicaid supplemental programs contributed approximately $240 million to adjusted EBITDA, underscoring the importance of these programs.
Guidance for the year was raised in response to favorable performance and a positive outlook for the fourth quarter.
The company remains focused on enhancing operational capabilities and investments in patient care services and digital tools.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit HCA on AllInvestView.